CN111820314A - A kind of anti-fatigue health care product prepared by using deer blood polypeptide and wolfberry polysaccharide - Google Patents
A kind of anti-fatigue health care product prepared by using deer blood polypeptide and wolfberry polysaccharide Download PDFInfo
- Publication number
- CN111820314A CN111820314A CN202010774065.7A CN202010774065A CN111820314A CN 111820314 A CN111820314 A CN 111820314A CN 202010774065 A CN202010774065 A CN 202010774065A CN 111820314 A CN111820314 A CN 111820314A
- Authority
- CN
- China
- Prior art keywords
- deer blood
- blood polypeptide
- fatigue
- polypeptide
- enzymatic hydrolysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000282994 Cervidae Species 0.000 title claims abstract description 62
- 239000008280 blood Substances 0.000 title claims abstract description 62
- 210000004369 blood Anatomy 0.000 title claims abstract description 62
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 53
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 52
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 51
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 29
- 244000241838 Lycium barbarum Species 0.000 title abstract description 17
- 235000015459 Lycium barbarum Nutrition 0.000 title abstract description 17
- 235000015468 Lycium chinense Nutrition 0.000 title abstract description 16
- 150000004676 glycans Chemical class 0.000 title abstract description 9
- 229920001282 polysaccharide Polymers 0.000 title abstract description 9
- 239000005017 polysaccharide Substances 0.000 title abstract description 9
- 230000000694 effects Effects 0.000 claims abstract description 26
- 230000007071 enzymatic hydrolysis Effects 0.000 claims abstract description 14
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims abstract description 14
- 239000004365 Protease Substances 0.000 claims abstract description 12
- 239000008518 lycium barbarum polysaccharide Substances 0.000 claims abstract description 11
- 108010004032 Bromelains Proteins 0.000 claims abstract description 9
- 102000029816 Collagenase Human genes 0.000 claims abstract description 9
- 108060005980 Collagenase Proteins 0.000 claims abstract description 9
- 229960002424 collagenase Drugs 0.000 claims abstract description 9
- 235000019835 bromelain Nutrition 0.000 claims abstract description 8
- 235000013305 food Nutrition 0.000 claims abstract description 7
- 239000000047 product Substances 0.000 claims description 19
- 239000012528 membrane Substances 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 238000010008 shearing Methods 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 7
- 238000000265 homogenisation Methods 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 229940088598 enzyme Drugs 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000005374 membrane filtration Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 13
- 230000009182 swimming Effects 0.000 description 11
- 239000007910 chewable tablet Substances 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000284 extract Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 4
- 235000020776 essential amino acid Nutrition 0.000 description 4
- 239000003797 essential amino acid Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229940068682 chewable tablet Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 239000005996 Blood meal Substances 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000001471 micro-filtration Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 241000282985 Cervus Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 230000006993 memory improvement Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- -1 tyrosine amino acid Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/345—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of blood proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/06—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from blood
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/12—Animal proteins from blood
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供一种鹿血多肽,所制备的鹿血多肽和枸杞多糖作为有效成分来制备具有抗疲劳作用的组合物;所制备的组合物具有协同增效作用,可用于缓解疲劳的食品、功能食品、特殊医学用途食品和药品。本发明使用胶原蛋白酶和菠萝蛋白酶对鹿血进行酶解制备的鹿血多肽,和枸杞多糖联合使用,鹿血多肽和枸杞多糖组合物的抗疲劳活性明显高于单一的鹿血多肽和枸杞多糖的活性。
The invention provides a deer blood polypeptide. The prepared deer blood polypeptide and wolfberry polysaccharide are used as effective ingredients to prepare a composition with anti-fatigue effect; the prepared composition has a synergistic effect, and can be used for food and functional products for relieving fatigue. Foodstuffs, Foodstuffs for Special Medical Purposes and Medicines. In the invention, the deer blood polypeptide prepared by enzymatic hydrolysis of deer blood with collagenase and bromelain is used in combination with lycium barbarum polysaccharide. active.
Description
技术领域technical field
本发明属于活性物质提取应用技术领域,具体涉及一种鹿血多肽以及使用鹿血多肽和枸杞多糖联合制备的抗疲劳保健品。The invention belongs to the technical field of active substance extraction and application, in particular to a deer blood polypeptide and an anti-fatigue health care product prepared by using the deer blood polypeptide and wolfberry polysaccharide jointly.
背景技术Background technique
疲劳是指躯体在生理活动过程中不能开始或持续某一特定强度的活动状态。在当今社会,由于工作生活节奏加快、作息不规律等因素,很多人长期承受着较大心理压力或处于超时超负荷劳作状态,长此以往,身体的重要器官功能就会失调,从而出现疲劳症状,如头昏、头痛、食欲不振、精神不佳、记忆力减退等。据世界卫生组织调查,全球约有35%以上的人处于疲劳状态,尤其是中年男性人群疲劳状态者高达60%-75%。疲劳能造成氧自由基积累、免疫功能失调等,从而导致其他疾病的发生、发展,严重影响人们的工作和生活。因此,能够缓解人体疲劳的产品越来越受到人们的关注。Fatigue refers to the inability of the body to initiate or sustain a certain intensity of activity during physical activity. In today's society, due to the accelerated pace of work and life, irregular work and rest and other factors, many people have been under greater psychological pressure for a long time or are in a state of overworked overload. Dizziness, headache, loss of appetite, poor energy, memory loss, etc. According to a survey by the World Health Organization, more than 35% of people in the world are in a state of fatigue, especially among middle-aged men who are in a state of fatigue as high as 60%-75%. Fatigue can cause the accumulation of oxygen free radicals, immune dysfunction, etc., which can lead to the occurrence and development of other diseases, and seriously affect people's work and life. Therefore, products that can relieve human fatigue have attracted more and more attention.
鹿血在民间也广为流传,视为中药之上品。《本草纲目》中记载为大补虚损,益精血,解痘毒、药毒等。近代,通过动物实验和临床研究证明了鹿血具有养颜容、治疗贫血,调节免疫,延缓衰老,改善记忆,抗疲劳,改善性功能等多项生理学活性。但若直接食用鹿血干粉作为抗疲劳制品,其血腥味较重,适口性差;此外,不易被人体吸收消化,导致抗疲劳效果不佳,需要增加食用量;而正常人每次服用鹿血粉的数量超过20克,会导致食用者出现上火等不适症状。Deer blood is also widely circulated among the people and is regarded as the top quality of traditional Chinese medicine. "Compendium of Materia Medica" is recorded as a great tonic for deficiency, nourishing essence and blood, detoxification of pox, drug poison and so on. In modern times, animal experiments and clinical studies have proved that deer blood has many physiological activities such as beauty, treatment of anemia, immune regulation, anti-aging, improvement of memory, anti-fatigue, and improvement of sexual function. However, if the deer blood dry powder is directly consumed as an anti-fatigue product, it will have a heavy bloody smell and poor palatability; in addition, it is not easy to be absorbed and digested by the human body, resulting in poor anti-fatigue effect, and the consumption needs to be increased; If the amount exceeds 20 grams, it will cause the user to experience discomfort such as getting angry.
枸杞多糖是枸杞中最主要的活性成分,已有研究显示枸杞多糖具有显著抗疲劳、抗衰老、增强免疫作用。所制备的鹿血多肽和枸杞多糖作为有效成分,研究其抗疲劳功能,旨在研发缓解疲劳的食品、功能食品、特殊医学用途食品和药品。Lycium barbarum polysaccharide is the most important active ingredient in Lycium barbarum. Studies have shown that Lycium barbarum polysaccharide has significant anti-fatigue, anti-aging and immune-enhancing effects. The prepared deer blood polypeptide and Lycium barbarum polysaccharide are used as active ingredients to study their anti-fatigue function, aiming to develop food, functional food, food for special medical purpose and medicine for relieving fatigue.
发明内容SUMMARY OF THE INVENTION
本发明的目的是提供一种鹿血多肽,所制备的鹿血多肽和枸杞多糖作为有效成分来制备具有抗疲劳作用的组合物;所制备的组合物具有协同增效作用,可用于缓解疲劳的食品、功能食品、特殊医学用途食品和药品。The purpose of the present invention is to provide a deer blood polypeptide. The prepared deer blood polypeptide and Lycium barbarum polysaccharide are used as active ingredients to prepare a composition with anti-fatigue effect; the prepared composition has a synergistic effect and can be used for relieving fatigue. Food, functional food, food for special medical purpose and medicine.
本发明首先提供一种鹿血多肽,其制备方法如下:The present invention first provides a deer blood polypeptide, and its preparation method is as follows:
1)匀浆:将待提取的鹿血进行匀浆,制成匀浆液;1) Homogenization: homogenize the deer blood to be extracted to prepare a homogenate;
匀浆的条件如下:高速剪切机转速为8000-12000rpm,剪切时间为30-50min;The conditions of homogenization are as follows: the rotating speed of the high-speed shearing machine is 8000-12000rpm, and the shearing time is 30-50min;
2)酶解:向步骤1)的匀浆液中加入胶原蛋白酶和菠萝蛋白酶进行酶解,得到酶解液,离心取上清液;2) Enzymatic hydrolysis: adding collagenase and bromelain to the homogenate in step 1) for enzymatic hydrolysis to obtain an enzymatic hydrolysis solution, and centrifuging to get the supernatant;
作为优选,胶原蛋白酶和菠萝蛋白酶的酶活比为1:10;Preferably, the enzyme activity ratio of collagenase and bromelain is 1:10;
所述的酶解条件,是在35-55℃酶解3-5h;The enzymolysis conditions are 3-5h at 35-55°C;
作为实施例的一种具体记载,是在50℃酶解5h;As a specific record of the embodiment, enzymatic hydrolysis was performed at 50°C for 5h;
所述的离心的转速为>6000rpm;The rotating speed of described centrifugation is >6000rpm;
3)膜过滤:对步骤2)制备的上清液,首先用分子量为3500Da的膜进行过滤,再用160Da的膜进行过滤,过滤液即为鹿血多肽溶液;3) Membrane filtration: the supernatant prepared in step 2) is first filtered with a membrane with a molecular weight of 3500Da, and then with a 160Da membrane, and the filtrate is the deer blood polypeptide solution;
4)干燥:步骤3)中的鹿血多肽浓缩液,经喷雾干燥得到鹿血多肽粉。4) Drying: the deer blood polypeptide concentrate in step 3) is spray-dried to obtain deer blood polypeptide powder.
本发明所提供的鹿血多肽用于制备具有抗疲劳作用的食品或保健品;The deer blood polypeptide provided by the present invention is used for preparing food or health care product with anti-fatigue effect;
本发明另一个方面提供一种抗疲劳保健品,是使用上述方法制备的鹿血多肽;Another aspect of the present invention provides an anti-fatigue health care product, which is a deer blood polypeptide prepared by the above method;
上述的抗疲劳保健品中,还添加有枸杞多糖。Lycium barbarum polysaccharide is also added to the above anti-fatigue health care products.
本发明制备的鹿血多肽和枸杞多糖联合使用,鹿血多肽和枸杞多糖组合物的抗疲劳活性明显高于单一的鹿血多肽和枸杞多糖的活性。The deer blood polypeptide prepared by the invention and the wolfberry polysaccharide are used in combination, and the anti-fatigue activity of the combination of the deer blood polypeptide and the wolfberry polysaccharide is obviously higher than that of the single deer blood polypeptide and the wolfberry polysaccharide.
附图说明Description of drawings
图1:小鼠力竭游泳实验图。Figure 1: Diagram of the exhaustive swimming experiment in mice.
具体实施方式Detailed ways
鹿血多肽是由鹿血蛋白酶解而来的分子量在500-2000Da的多肽,是鹿血中发挥上述功能的主要活性物质。鹿血蛋白酶解后不仅有利于机体吸收,而且能够提高生理学活性。已有的研究中使用木瓜蛋白酶和碱性蛋白酶对驼血进行酶解,制备的多肽抗疲劳活性并不好。因此,本发明以马鹿血为研究对象,系统考察酶解鹿血蛋白合适的蛋白酶及比例,将鹿血高效合理的分解为抗疲劳活性最高的活性肽。Deer blood polypeptide is a polypeptide with a molecular weight of 500-2000 Da, which is hydrolyzed by deer blood protease, and is the main active substance in deer blood that exerts the above functions. Deer blood protease hydrolysis is not only beneficial to the body's absorption, but also can improve the physiological activity. In existing studies, papain and alkaline protease were used to hydrolyze camel blood, and the anti-fatigue activity of the prepared polypeptide was not good. Therefore, the present invention takes red deer blood as the research object, systematically investigates the appropriate protease and proportion for enzymatic hydrolysis of deer blood protein, and deer blood is efficiently and reasonably decomposed into active peptides with the highest anti-fatigue activity.
下面结合实施例对本发明进行详细的描述。The present invention will be described in detail below with reference to the embodiments.
实施例1鹿血多肽制备方法的筛选Example 1 Screening of Deer Blood Polypeptide Preparation Method
取鹿血10kg,高速剪切匀浆后,加入3%鹿血重量的不同的酶,在50℃酶解3h,通过对不同酶解产物进行筛选,发现胶原蛋白酶和菠萝蛋白酶的酶解产物能够明显增加小鼠的游泳时间(表1),说明上述两种酶解产物具有抗疲劳的作用。10kg of deer blood was taken, homogenized by high-speed shearing, added with 3% of the weight of deer blood with different enzymes, and enzymatically hydrolyzed at 50 °C for 3 hours. The swimming time of the mice was significantly increased (Table 1), indicating that the above two enzymatic hydrolysates have anti-fatigue effects.
表1不同酶解产物的大鼠力竭游泳实验表Table 1 The exhaustive swimming experiment of rats with different enzymolysis products
*p<0.05,差异有显著性*p<0.05, the difference is significant
为了进一步提高酶解产物的得率和抗疲劳效果,将胶原蛋白酶和菠萝蛋白酶进行复配,通过改变酶活比例,筛选抗疲劳效果。In order to further improve the yield and anti-fatigue effect of enzymolysis products, collagenase and bromelain were compounded, and the anti-fatigue effect was screened by changing the ratio of enzyme activity.
结果显示,胶原蛋白酶和菠萝蛋白酶酶活比例为1:10时,组合物的抗疲劳活性最好(如表2所示),酶解产物经10000rpm离心后,上清液先用3500Da的膜分离,然后用160Da的膜分离,得到了三个组分的酶解产物,通过对三组产物进行活性筛选The results showed that when the ratio of collagenase and bromelain enzyme activities was 1:10, the anti-fatigue activity of the composition was the best (as shown in Table 2). , and then separated with a 160Da membrane to obtain three components of enzymatic hydrolysis products, by screening the activities of the three groups of products
表2:不同酶活比例酶解产物的大鼠力竭游泳实验Table 2: Rat exhaustive swimming experiment of enzymatic hydrolysis products with different enzyme activity ratios
*p<0.05,差异有显著性*p<0.05, the difference is significant
结果发现,分子量在160Da-3500Da之间的产物,抗疲劳的效果最好(如表3所示)。最终得到鹿血多肽酶解产物,经喷雾干燥得到鹿血多肽粉0.85kg。It was found that the products with molecular weights between 160Da-3500Da had the best anti-fatigue effect (as shown in Table 3). Finally, the enzymatic hydrolysis product of deer blood polypeptide was obtained, and 0.85 kg of deer blood polypeptide powder was obtained by spray drying.
表3:不同分子量多肽的大鼠力竭游泳实验Table 3: Rat exhaustive swimming experiment with different molecular weight polypeptides
*p<0.05,差异有显著性*p<0.05, the difference is significant
最终本发明确定的制备具有抗疲劳作用的鹿血多肽的制备方法,其具体步骤如下:Finally, the specific steps of the preparation method of the deer blood polypeptide with anti-fatigue effect determined in the present invention are as follows:
1)匀浆:将待提取的鹿血进行匀浆,制成匀浆液;1) Homogenization: homogenize the deer blood to be extracted to prepare a homogenate;
匀浆的一种具体条件如下:高速剪切机转速为8000-12000rpm,剪切时间为30-50min;A specific condition of homogenization is as follows: the rotating speed of the high-speed shearing machine is 8000-12000rpm, and the shearing time is 30-50min;
2)酶解:向步骤1)的匀浆液中加入胶原蛋白酶和菠萝蛋白酶进行酶解,得到酶解液,离心取上清液;其中胶原蛋白酶和菠萝蛋白酶在匀浆液的加入量比值为1:50-5:1,酶解条件是在35-55℃酶解3-5h;所述的离心的转速为>6000rpm;2) enzymolysis: in the homogenate of step 1), add collagenase and bromelain to carry out enzymolysis, obtain enzymolysis solution, and centrifuge to get supernatant; wherein the ratio of the addition of collagenase and bromelain in homogenate is 1: 50-5:1, the enzymolysis conditions are 3-5h at 35-55°C; the speed of the centrifugation is >6000rpm;
3)膜过滤:对步骤2)制备的上清液先用分子量3500Da的膜进行过滤,再用160Da的膜进行过滤,过滤液即为鹿血多肽溶液;3) Membrane filtration: the supernatant liquid prepared in step 2) is first filtered with a membrane with a molecular weight of 3500Da, and then with a membrane of 160Da, and the filtrate is the deer blood polypeptide solution;
4)干燥:步骤3)中的鹿血多肽浓缩液,经喷雾干燥得到鹿血多肽粉。4) Drying: the deer blood polypeptide concentrate in step 3) is spray-dried to obtain deer blood polypeptide powder.
实施例2:Example 2:
使用实施例1所确定的方法,采用上述条件制成鹿血多肽,经凯氏定氮法测定,多肽含量为87.65%,该多肽包含甘氨酸、谷氨酸、精氨酸、赖氨酸、酪氨酸,总氨基酸含量(TAA)达到75.58%,其中必需氨基酸(EAA)含量为36.51%,EAA/TAA值为49.13%,EAA/NEAA值为98%;第一限制性氨基酸为色氨酸。Using the method determined in Example 1, the deer blood polypeptide was prepared under the above conditions, and the content of the polypeptide was 87.65% as determined by Kjeldahl method, and the polypeptide contained glycine, glutamic acid, arginine, lysine, tyrosine amino acid, the total amino acid content (TAA) reached 75.58%, of which the essential amino acid (EAA) content was 36.51%, the EAA/TAA value was 49.13%, and the EAA/NEAA value was 98%; the first limiting amino acid was tryptophan.
表4:鹿血多肽氨基酸含量(单位:%)Table 4: Deer blood polypeptide amino acid content (unit: %)
力竭游泳实验(图1)结果表明,小鼠给予鹿血多肽游泳时间显著增强(P<0.05),在3种剂量水平下均能较好的缓解体力疲劳。特别的,在同等浓度剂量下,使用鹿血粉的作用较鹿血多肽明显偏低。因此,通过本实施例1所确定方法,所得鹿血多肽显著增强了其缓解体力疲劳的作用。The results of exhaustive swimming experiment (Fig. 1) showed that the swimming time of mice given deer blood polypeptide was significantly enhanced (P<0.05), and physical fatigue could be better relieved at the three dose levels. In particular, at the same concentration and dose, the effect of using deer blood meal is significantly lower than that of deer blood polypeptide. Therefore, by the method determined in this Example 1, the obtained deer blood polypeptide significantly enhanced its effect of relieving physical fatigue.
表5:多肽及鹿血粉大鼠力竭游泳实验Table 5: Peptide and Deer Blood Meal Rats Exhausted Swimming Experiment
*p<0.05,差异有显著性*p<0.05, the difference is significant
实施例3:枸杞多糖的制备Example 3: Preparation of Lycium barbarum polysaccharide
取5公斤枸杞子依次用自来水、纯净水清洗,干燥后粉碎,过15目筛。将粉碎过筛的枸杞子加入亚临界提取装置中,再加入25m3的丁烷。充氮气10min后,进行亚临界萃取。萃取压力5MPa,萃取时间30min。脱溶剂,收集枸杞脂溶性成分和枸杞子渣。将上述枸杞子渣,加入5倍去离子水,用高速剪切机剪切30min获得枸杞子浸泡液,剪切的转速为10000rpm。将上述经剪切的枸杞子浸泡液转移到提取罐,再加入7倍体积的去离子水提取2h,提取温度60℃;第2次提取加入10倍量的去离子水。提取结束后用管式离心机离心,离心转速为16000rpm。2次提取后合并得到提取液Ⅰ。将上述提取液Ⅰ通过分子量为100万的微滤膜系统,过膜温度50℃,压力为2bar。收集透过微滤膜的提取液,得提取液Ⅱ。将上述提取液Ⅱ通过分子量为1000的超滤膜系统进行浓缩,过滤温度30℃,压力为10bar。收集超滤膜截留的提取液,得提取液Ⅲ。将提取液Ⅲ继续减压浓缩,温度小于60℃。当浓缩至体积为枸杞子原料质量的2.5倍时,将其置于醇沉罐。一边搅拌一边加入乙醇,使其乙醇的浓度达到75%后,继续搅拌30min。静止8h。分离并回收上清液,沉淀物鼓风干燥12h,干燥温度65℃。得棕色枸杞多糖。上述产品用苯酚硫酸法进行含量测定,枸杞多糖的含量为53.21%Take 5 kilograms of wolfberry fruit, wash with tap water and purified water in turn, pulverize after drying, and pass through a 15-mesh sieve. Add the crushed and sieved wolfberry fruit into the subcritical extraction device, and then add 25m 3 of butane. After 10 min of nitrogen gas, subcritical extraction was performed. The extraction pressure was 5MPa, and the extraction time was 30min. The solvent was removed, and the fat-soluble components of wolfberry and the residue of wolfberry were collected. Add 5 times of deionized water to the above-mentioned wolfberry slag, and shear it with a high-speed shearing machine for 30 minutes to obtain a wolfberry soaking solution, and the shearing speed is 10,000 rpm. Transfer the sheared medlar soaking solution to the extraction tank, and then add 7 times the volume of deionized water to extract for 2 hours, and the extraction temperature is 60 ° C; for the second extraction, add 10 times the amount of deionized water. After the extraction, centrifuge with a tube centrifuge at 16,000 rpm. After 2 extractions, the extraction solution I was obtained by combining. The above-mentioned extract I was passed through a microfiltration membrane system with a molecular weight of 1 million at a temperature of 50° C. and a pressure of 2 bar. Collect the extract that passes through the microfiltration membrane to obtain the extract II. The above-mentioned extract II was concentrated through an ultrafiltration membrane system with a molecular weight of 1000, the filtration temperature was 30 °C, and the pressure was 10 bar. Collect the extraction solution retained by the ultrafiltration membrane to obtain extraction solution III. Continue to concentrate the extract III under reduced pressure, and the temperature is less than 60°C. When concentrated to a volume of 2.5 times the mass of the raw material of wolfberry, it is placed in an alcohol precipitation tank. While stirring, ethanol was added to make the ethanol concentration reach 75%, and then the stirring was continued for 30 min. Still 8h. The supernatant was separated and recovered, and the precipitate was air-dried for 12 h at a drying temperature of 65°C. Obtain brown wolfberry polysaccharide. The above-mentioned products are determined by the phenol-sulfuric acid method, and the content of Lycium barbarum polysaccharide is 53.21%.
实施例4制备抗疲劳咀嚼片Example 4 Preparation of anti-fatigue chewable tablets
将750g鹿血多肽、750g枸杞多糖、500g甘露醇、500g木糖醇、500g乳糖,8.5g枸橼酸混匀,加入聚维酮2.5%和羧甲基纤维素钙3%造粒,60℃真空干燥,得到干颗粒。干颗粒过12目尼龙筛整理,然后将此颗粒与10.5g的硬脂酸镁,10.5g的滑石粉充分混合,再过12目尼龙筛,颗粒经含量测定合格后,用12mm冲压片,灭菌、包装得到咀嚼片。Mix 750g deer blood polypeptide, 750g wolfberry polysaccharide, 500g mannitol, 500g xylitol, 500g lactose, 8.5g citric acid, add 2.5% povidone and 3% carboxymethyl cellulose calcium to granulate, 60 ℃ Dry in vacuo to give dry granules. The dry granules are sorted through a 12-mesh nylon sieve, then the granules are fully mixed with 10.5g of magnesium stearate and 10.5g of talc, and then passed through a 12-mesh nylon sieve. bacteria and packaging to obtain chewable tablets.
对制得的咀嚼片进行质量检测,结果如下:The quality inspection of the prepared chewable tablets is as follows:
1、感官指标1. Sensory indicators
表6:咀嚼片感官品质分析结果表Table 6: Chewable Tablets Sensory Quality Analysis Results
2、理化指标:2. Physical and chemical indicators:
咀嚼片平均片重为1g/片,片重差异<3%。按照中国药典的规定对咀嚼片的重金属含量进行测定,测定结果为铅<0.2mg/kg,砷<0.1mg/kg。Chewable tablets had an average tablet weight of 1 g/tablet, and the difference in tablet weight was <3%. The heavy metal content of the chewable tablet was determined according to the provisions of the Chinese Pharmacopoeia, and the results were as follows: lead < 0.2 mg/kg, arsenic < 0.1 mg/kg.
依据中国药典规定的微生物限度检测法对咀嚼片进行微生物检测,检测结果如下:细菌总数<1000cfu/g,霉菌总数<20,大肠菌群、金黄色葡萄球菌和沙门氏菌均未检出。According to the microbial limit test method specified in the Chinese Pharmacopoeia, the chewable tablets were tested for microorganisms, and the test results were as follows: the total number of bacteria <1000cfu/g, the total number of molds <20, and no coliform bacteria, Staphylococcus aureus and Salmonella were detected.
3、硬度指标:3. Hardness index:
对咀嚼片的硬度进行测试,测试结果为4kg左右,完全符合片剂规定。The hardness of the chewable tablet is tested, and the test result is about 4kg, which fully complies with the tablet regulations.
实施例5:抗疲劳咀嚼片的效果Example 5: Effect of anti-fatigue chewable tablet
取实施例4制备的咀嚼片,溶于蒸馏水中;调整鹿血多肽和枸杞多糖总浓度分别为200mg/ml、400mg/ml、800mg/ml。样品现用现配。大鼠75只,随机分为5组,空白对照组不给予任何操作,其余各组动物每天灌胃给予相应药物1ml/100g,1次/d,连续30天。末次给受试样品24小时后,采用尾部负重3%体重铅皮的大鼠置于游泳箱中游泳。水深不少于50cm,水温31℃±1.0℃,当大鼠游至连续3次没入水底,每次超过10秒,视为力竭。The chewable tablets prepared in Example 4 were taken and dissolved in distilled water; the total concentrations of deer blood polypeptide and wolfberry polysaccharide were adjusted to be 200 mg/ml, 400 mg/ml and 800 mg/ml, respectively. Samples are available now. Seventy-five rats were randomly divided into 5 groups. The blank control group was not given any operation. The other groups were given the corresponding drug 1ml/100g by gavage every day, once/d, for 30 consecutive days. 24 hours after the last administration of the test samples, the rats with tails bearing 3% body weight lead skin were used to swim in the swimming box. The water depth is not less than 50cm, and the water temperature is 31℃±1.0℃. When the rat swims to the bottom of the water for 3 consecutive times for more than 10 seconds each time, it is regarded as exhausted.
表7:鹿血多肽和枸杞多糖组合物的大鼠力竭游泳实验表Table 7: Deer blood polypeptide and Lycium barbarum polysaccharide composition of rat exhaustive swimming test table
*p<0.05,差异有显著性*p<0.05, the difference is significant
由表5中的数据显示,高剂量组大鼠的力竭游泳时间明显高于空白对照组,说明高剂量鹿血多肽和枸杞多糖具有抗疲劳的功效。The data in Table 5 shows that the exhaustive swimming time of the rats in the high-dose group was significantly higher than that in the blank control group, indicating that the high-dose deer blood polypeptide and Lycium barbarum polysaccharide have anti-fatigue effects.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010774065.7A CN111820314A (en) | 2020-08-04 | 2020-08-04 | A kind of anti-fatigue health care product prepared by using deer blood polypeptide and wolfberry polysaccharide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010774065.7A CN111820314A (en) | 2020-08-04 | 2020-08-04 | A kind of anti-fatigue health care product prepared by using deer blood polypeptide and wolfberry polysaccharide |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111820314A true CN111820314A (en) | 2020-10-27 |
Family
ID=72919351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010774065.7A Pending CN111820314A (en) | 2020-08-04 | 2020-08-04 | A kind of anti-fatigue health care product prepared by using deer blood polypeptide and wolfberry polysaccharide |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111820314A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112451655A (en) * | 2020-12-10 | 2021-03-09 | 中国科学院兰州化学物理研究所 | Anti-fatigue composition and application thereof |
CN112662724A (en) * | 2021-01-20 | 2021-04-16 | 重庆市药物种植研究所 | Deer blood polypeptide and extraction method and application thereof |
CN114304067A (en) * | 2022-02-03 | 2022-04-12 | 兰州大学 | Method for establishing compound-factor-induced fatigue mouse model and anti-fatigue composition |
CN114391651A (en) * | 2021-11-25 | 2022-04-26 | 湖州维义生物科技股份有限公司 | Special sports nutritional compound deer raw material food and preparation method thereof |
CN118716553A (en) * | 2024-07-12 | 2024-10-01 | 鑫康国际医药生物科技(广州)有限公司 | Solid beverage of polysaccharide deer blood peptide for enhancing immunity and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4076701A (en) * | 1975-07-29 | 1978-02-28 | Immunology Research Foundation, Inc. | Tumor complement fraction recovery method and product |
CN103255186A (en) * | 2013-04-23 | 2013-08-21 | 集美大学 | Combined production method for abalone polysaccharide, lipid and protein peptide |
CN105146544A (en) * | 2015-10-14 | 2015-12-16 | 中国科学院兰州化学物理研究所 | Deer blood polypeptide soft capsule and preparation method thereof |
CN107217082A (en) * | 2017-06-05 | 2017-09-29 | 深圳知本康业有限公司 | A kind of deer hemalbumin polypeptide and application |
CN107557423A (en) * | 2017-10-27 | 2018-01-09 | 中国科学院兰州化学物理研究所 | A kind of preparation method of camel hemalbumin polypeptide |
CN107890473A (en) * | 2017-11-27 | 2018-04-10 | 中国科学院兰州化学物理研究所 | A kind of composition with fatigue-relieving and Yang strengthening function |
-
2020
- 2020-08-04 CN CN202010774065.7A patent/CN111820314A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4076701A (en) * | 1975-07-29 | 1978-02-28 | Immunology Research Foundation, Inc. | Tumor complement fraction recovery method and product |
CN103255186A (en) * | 2013-04-23 | 2013-08-21 | 集美大学 | Combined production method for abalone polysaccharide, lipid and protein peptide |
CN105146544A (en) * | 2015-10-14 | 2015-12-16 | 中国科学院兰州化学物理研究所 | Deer blood polypeptide soft capsule and preparation method thereof |
CN107217082A (en) * | 2017-06-05 | 2017-09-29 | 深圳知本康业有限公司 | A kind of deer hemalbumin polypeptide and application |
CN107557423A (en) * | 2017-10-27 | 2018-01-09 | 中国科学院兰州化学物理研究所 | A kind of preparation method of camel hemalbumin polypeptide |
CN107890473A (en) * | 2017-11-27 | 2018-04-10 | 中国科学院兰州化学物理研究所 | A kind of composition with fatigue-relieving and Yang strengthening function |
Non-Patent Citations (2)
Title |
---|
尹晓平等: "酶解天山马鹿血分离制备抗疲劳肽的研究", 《天然产物研究与开发》 * |
陈丽娜等: "生物活性肽制备工艺的研究进展", 《农产品加工》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112451655A (en) * | 2020-12-10 | 2021-03-09 | 中国科学院兰州化学物理研究所 | Anti-fatigue composition and application thereof |
CN112662724A (en) * | 2021-01-20 | 2021-04-16 | 重庆市药物种植研究所 | Deer blood polypeptide and extraction method and application thereof |
CN112662724B (en) * | 2021-01-20 | 2023-04-28 | 重庆市药物种植研究所 | Deer blood polypeptide and extraction method and application thereof |
CN114391651A (en) * | 2021-11-25 | 2022-04-26 | 湖州维义生物科技股份有限公司 | Special sports nutritional compound deer raw material food and preparation method thereof |
CN114304067A (en) * | 2022-02-03 | 2022-04-12 | 兰州大学 | Method for establishing compound-factor-induced fatigue mouse model and anti-fatigue composition |
CN114304067B (en) * | 2022-02-03 | 2024-01-09 | 兰州大学 | Method for establishing compound factor fatigue-induced mouse model and anti-fatigue composition |
CN118716553A (en) * | 2024-07-12 | 2024-10-01 | 鑫康国际医药生物科技(广州)有限公司 | Solid beverage of polysaccharide deer blood peptide for enhancing immunity and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111820314A (en) | A kind of anti-fatigue health care product prepared by using deer blood polypeptide and wolfberry polysaccharide | |
JP6828054B2 (en) | Walnut oligopeptide powder, its preparation method and use | |
CN111670997B (en) | Preparation method of immunity-enhancing compound protein peptide enzymatic hydrolysate, immunity-enhancing compound protein peptide beverage and preparation method thereof | |
TWI782283B (en) | Use of walnut oligopeptide powder | |
CN108853486B (en) | Formula product with function of enhancing immunity | |
TWI516280B (en) | Use of chenopodium formosanum extract for manufacture of composition for enhancing secretion of collagen and preventing cutaneous aging | |
CN104207150A (en) | Oral liquid containing soybean peptides and fungi polysaccharides and preparation method thereof | |
JP4917584B2 (en) | Processed solubilized bees, method for producing the same, antioxidant, ACE inhibitor, antihypertensive agent, dermal fibroblast proliferation promoter, fatigue recovery agent, blood flow improving agent, and solubilized bees Pharmaceuticals, cosmetics or food / drinks contained | |
CN113249421B (en) | A kind of rubyrin polypeptide and its preparation and application | |
CN109793885B (en) | A kind of preparation method of composite polypeptide for preventing or alleviating anemia | |
CN108743500A (en) | Not only oral administration but also can external application beautifying face and moistering lotion compound peptide functional food and preparation method thereof | |
WO2005096840A1 (en) | Kiwifruit extracts and extraction methods | |
CN111657501A (en) | Oyster peptide cordyceps sinensis mycelium composition with function of enhancing immunity and application thereof | |
CN109527190A (en) | The preparation method and applications of the compound small molecule Gly-His-Lys of black fungus | |
JP4484014B2 (en) | Hyaluronidase inhibition, antiallergic activity and immunostimulatory substances | |
CN109007848B (en) | Compound oligopeptide capable of improving sexual function and resisting fatigue, oral preparation of compound oligopeptide and preparation method of oral preparation | |
CN107439787B (en) | Walnut oligopeptide with PM 2.5 particle resistance effect | |
CN109589400B (en) | Composition with neuroprotective effect | |
CN112273656A (en) | Black garlic oral liquid capable of enhancing immunity and preparation method thereof | |
CN110856744B (en) | New application of dendrobe polypeptide | |
CN108402473B (en) | Oral brain polypeptide composition with memory improving function | |
CN116726140A (en) | Shark liver peptide compound product for dispelling effects of alcohol and protecting liver and application thereof | |
CN116898098A (en) | Boletus peptide anti-alcoholic formula and raw material preparation method | |
CN105558896A (en) | Composition containing effective components of sea cucumber and cordyceps sinensis, preparation method and application thereof | |
CN107439866A (en) | Matrimony vine chickpea plant nutrients beverage and its preparation technology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |